New Pharmacological Treatment Approaches for Anxiety Disorders

摘要: New developments in the pharmacological treatment of anxiety disorders will have distinct backgrounds: characterization pathophysiological processes including evolving techniques genomics and proteomics generate new drug targets. Drug development design substances with specific action at neurotransmitter neuropeptide receptors or affecting their reuptake metabolism. anxiolytic drugs may target receptor systems that only recently been linked to anxiety-related behavior. This includes N-methyl-D-aspartate (NMDA), S-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), cannabinoid receptors. In addition, signal transduction pathways, neurotrophic factors, gases such as nitric oxide carbon monoxide be Combining psychopharmacological psychotherapeutical interventions is a further field where benefits for could achieved. Although road arduous, improvements are expected near future.